CoChat
Sign Up
Cited by 83

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

MT1-MMP Inactivates ADAM9 to Regulate FGFR2 Signaling and Calvarial Osteogenesis

Chan, Kui Ming, Wong, Hoi Leong Xavier, Jin, Guoxiang, Liu, Baohua, Cao, Renhai, Cao, Yihai, Lehti, Kaisa, Tryggvason, Karl, Zhou, Zhongjun·2012·Developmental Cell
DOI 10.1016/j.devcel.2012.04.014
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.devcel.2012.04.014

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 49

  1. Barbolina, 2008, Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis, Semin. Cell Dev. Biol., 19, 24, 10.1016/j.semcdb.2007.06.008 · DOI
  2. Cabrita, 2003, Sprouty proteins: antagonists of endothelial cell signaling and more, Thromb. Haemost., 90, 586, 10.1160/TH03-04-0217 · DOI
  3. Catela, 2009, Multiple congenital malformations of Wolf-Hirschhorn syndrome are recapitulated in Fgfrl1 null mice, Dis. Model. Mech., 2, 283, 10.1242/dmm.002287 · DOI
  4. Celli, 1998, Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning, EMBO J., 17, 1642, 10.1093/emboj/17.6.1642 · DOI
  5. Deng, 1994, Murine FGFR-1 is required for early postimplantation growth and axial organization, Genes Dev., 8, 3045, 10.1101/gad.8.24.3045 · DOI
  6. Ding, 2011, Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization, Cell, 147, 539, 10.1016/j.cell.2011.10.003 · DOI
  7. Foster, 2002, Enforced expression of FGF-7 promotes epithelial hyperplasia whereas a dominant negative FGFR2iiib promotes the emergence of neuroendocrine phenotype in prostate glands of transgenic mice, Differentiation, 70, 624, 10.1046/j.1432-0436.2002.700915.x · DOI
  8. Fürthauer, 2002, Sef is a feedback-induced antagonist of Ras/MAPK-mediated FGF signalling, Nat. Cell Biol., 4, 170, 10.1038/ncb750 · DOI
  9. Holmbeck, 1999, MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover, Cell, 99, 81, 10.1016/S0092-8674(00)80064-1 · DOI · Paper page
  10. Holmbeck, 2003, MT1-MMP-dependent, apoptotic remodeling of unmineralized cartilage: a critical process in skeletal growth, J. Cell Biol., 163, 661, 10.1083/jcb.200307061 · DOI
  11. Holmbeck, 2005, The metalloproteinase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone, J. Cell Sci., 118, 147, 10.1242/jcs.01581 · DOI
  12. Ignelzi, 2003, Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures, J. Bone Miner. Res., 18, 751, 10.1359/jbmr.2003.18.4.751 · DOI
  13. Inoue, 2006, A crucial role for matrix metalloproteinase 2 in osteocytic canalicular formation and bone metabolism, J. Biol. Chem., 281, 33814, 10.1074/jbc.M607290200 · DOI
  14. Kim, 1998, FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development, Development, 125, 1241, 10.1242/dev.125.7.1241 · DOI
  15. Kim, 2003, Erk pathway and activator protein 1 play crucial roles in FGF2-stimulated premature cranial suture closure, Dev. Dyn., 227, 335, 10.1002/dvdy.10319 · DOI
  16. Levi, 1996, Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1, Proc. Natl. Acad. Sci. USA, 93, 7069, 10.1073/pnas.93.14.7069 · DOI
  17. Li, 2010, Activation of FGF signaling mediates proliferative and osteogenic differences between neural crest derived frontal and mesoderm parietal derived bone, PLoS One, 5, e14033, 10.1371/journal.pone.0014033 · DOI
  18. Liu, 2009, TACE-mediated ectodomain shedding of the type I TGF-beta receptor downregulates TGF-beta signaling, Mol. Cell, 35, 26, 10.1016/j.molcel.2009.06.018 · DOI
  19. Liu, 2002, Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18, Genes Dev., 16, 859, 10.1101/gad.965602 · DOI
  20. Maas, 1996, The role of Msx genes in mammalian development, Ann. N Y Acad. Sci., 785, 171, 10.1111/j.1749-6632.1996.tb56256.x · DOI
  21. Maretzky, 2009, Src stimulates fibroblast growth factor receptor-2 shedding by an ADAM15 splice variant linked to breast cancer, Cancer Res., 69, 4573, 10.1158/0008-5472.CAN-08-4766 · DOI
  22. Maretzky, 2009, Characterization of the catalytic activity of the membrane-anchored metalloproteinase ADAM15 in cell-based assays, Biochem. J., 420, 105, 10.1042/BJ20082127 · DOI
  23. Maretzky, 2011, A transforming Src mutant increases the bioavailability of EGFR ligands via stimulation of the cell-surface metalloproteinase ADAM17, Oncogene, 30, 611, 10.1038/onc.2010.443 · DOI
  24. Maruyama, 2010, The balance of WNT and FGF signaling influences mesenchymal stem cell fate during skeletal development, Sci. Signal., 3, ra40, 10.1126/scisignal.2000727 · DOI
  25. Miettinen, 1999, Epidermal growth factor receptor function is necessary for normal craniofacial development and palate closure, Nat. Genet., 22, 69, 10.1038/8773 · DOI
  26. Miraoui, 2010, Fibroblast growth factor receptor signaling crosstalk in skeletogenesis, Sci. Signal., 3, re9, 10.1126/scisignal.3146re9 · DOI
  27. Mosig, 2007, Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth, Hum. Mol. Genet., 16, 1113, 10.1093/hmg/ddm060 · DOI
  28. Oblander, 2005, Distinctive functions of membrane type 1 matrix-metalloprotease (MT1-MMP or MMP-14) in lung and submandibular gland development are independent of its role in pro-MMP-2 activation, Dev. Biol., 277, 255, 10.1016/j.ydbio.2004.09.033 · DOI
  29. Ohbayashi, 2002, FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis, Genes Dev., 16, 870, 10.1101/gad.965702 · DOI
  30. Onguchi, 2009, Membrane type-1 matrix metalloproteinase potentiates basic fibroblast growth factor-induced corneal neovascularization, Am. J. Pathol., 174, 1564, 10.2353/ajpath.2009.080452 · DOI
  31. Ornitz, 2002, FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease, Genes Dev., 16, 1446, 10.1101/gad.990702 · DOI
  32. Peduto, 2009, ADAM9 as a potential target molecule in cancer, Curr. Pharm. Des., 15, 2282, 10.2174/138161209788682415 · DOI
  33. Peduto, 2005, Critical function for ADAM9 in mouse prostate cancer, Cancer Res., 65, 9312, 10.1158/0008-5472.CAN-05-1063 · DOI
  34. Powers, 2000, Fibroblast growth factors, their receptors and signaling, Endocr. Relat. Cancer, 7, 165, 10.1677/erc.0.0070165 · DOI · Paper page
  35. Ramasamy, 2007, Fgf10 dosage is critical for the amplification of epithelial cell progenitors and for the formation of multiple mesenchymal lineages during lung development, Dev. Biol., 307, 237, 10.1016/j.ydbio.2007.04.033 · DOI
  36. Rice, 2000, Integration of FGF and TWIST in calvarial bone and suture development, Development, 127, 1845, 10.1242/dev.127.9.1845 · DOI
  37. Satokata, 1994, Msx1 deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development, Nat. Genet., 6, 348, 10.1038/ng0494-348 · DOI
  38. Satokata, 2000, Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation, Nat. Genet., 24, 391, 10.1038/74231 · DOI · Paper page
  39. Schneider, 2009, The EGFR network in bone biology and pathology, Trends Endocrinol. Metab., 20, 517, 10.1016/j.tem.2009.06.008 · DOI
  40. Sleeman, 2001, Identification of a new fibroblast growth factor receptor, FGFR5, Gene, 271, 171, 10.1016/S0378-1119(01)00518-2 · DOI
  41. Smith, 2005, Feedback interactions between MKP3 and ERK MAP kinase control scleraxis expression and the specification of rib progenitors in the developing chick somite, Development, 132, 1305, 10.1242/dev.01699 · DOI
  42. Sugiyama, 2010, FGF receptor-4 (FGFR4) polymorphism acts as an activity switch of a membrane type 1 matrix metalloproteinase-FGFR4 complex, Proc. Natl. Acad. Sci. USA, 107, 15786, 10.1073/pnas.0914459107 · DOI
  43. Trueb, 2011, Biology of FGFRL1, the fifth fibroblast growth factor receptor, Cell. Mol. Life Sci., 68, 951, 10.1007/s00018-010-0576-3 · DOI
  44. Werb, 1997, ECM and cell surface proteolysis: regulating cellular ecology, Cell, 91, 439, 10.1016/S0092-8674(00)80429-8 · DOI
  45. Weskamp, 2002, Mice lacking the metalloprotease-disintegrin MDC9 (ADAM9) have no evident major abnormalities during development or adult life, Mol. Cell. Biol., 22, 1537, 10.1128/MCB.22.5.1537-1544.2002 · DOI
  46. Xu, 1998, Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction, Development, 125, 753, 10.1242/dev.125.4.753 · DOI
  47. Yamaguchi, 1994, fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation, Genes Dev., 8, 3032, 10.1101/gad.8.24.3032 · DOI
  48. Yu, 2003, Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth, Development, 130, 3063, 10.1242/dev.00491 · DOI
  49. Zhou, 2000, Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I, Proc. Natl. Acad. Sci. USA, 97, 4052, 10.1073/pnas.060037197 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Chan, K. M., Wong, H. L. X., Jin, G., Liu, B., Cao, R., Cao, Y., Lehti, K., Tryggvason, K., & Zhou, Z.
Venue
Developmental Cell
Publisher
Elsevier BV
Published
2012-06
Volume
22
Issue
6
Pages
1176-1190
ISSN
1534-5807
DOI
10.1016/j.devcel.2012.04.014
Cited by
83
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review